EKF Diagnostics Holdings Plc (EKF) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EKF Diagnostics Holdings Plc (EKF) has a cash flow conversion efficiency ratio of 0.068x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX4.92 Million ≈ $598.62 USD) by net assets (GBX72.88 Million ≈ $8.87K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EKF Diagnostics Holdings Plc - Cash Flow Conversion Efficiency Trend (2001–2024)
This chart illustrates how EKF Diagnostics Holdings Plc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EKF Diagnostics Holdings Plc total liabilities for a breakdown of total debt and financial obligations.
EKF Diagnostics Holdings Plc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EKF Diagnostics Holdings Plc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Focusrite Plc
LSE:TUNE
|
0.145x |
|
BlockMint Technologies Inc
V:BKMT
|
-0.024x |
|
Nusantara Inti Corpora Tbk
JK:UNIT
|
-0.084x |
|
Wang & Lee Group, Inc. Ordinary Shares
NASDAQ:WLGS
|
0.051x |
|
Arcandor AG
DU:ARO
|
N/A |
|
Antarctica Limited
NSE:ANTGRAPHIC
|
-0.337x |
|
Pharos Energy plc
LSE:PHAR
|
0.058x |
|
elexxion AG
XETRA:E8X
|
-708202.000x |
Annual Cash Flow Conversion Efficiency for EKF Diagnostics Holdings Plc (2001–2024)
The table below shows the annual cash flow conversion efficiency of EKF Diagnostics Holdings Plc from 2001 to 2024. For the full company profile with market capitalisation and key ratios, see EKF stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | GBX73.21 Million ≈ $8.91K |
GBX13.66 Million ≈ $1.66K |
0.187x | +101.62% |
| 2023-12-31 | GBX68.22 Million ≈ $8.30K |
GBX6.31 Million ≈ $767.87 |
0.093x | -28.84% |
| 2022-12-31 | GBX74.52 Million ≈ $9.07K |
GBX9.69 Million ≈ $1.18K |
0.130x | +20.30% |
| 2021-12-31 | GBX94.74 Million ≈ $11.53K |
GBX10.24 Million ≈ $1.25K |
0.108x | -38.80% |
| 2020-12-31 | GBX78.20 Million ≈ $9.51K |
GBX13.81 Million ≈ $1.68K |
0.177x | +146.43% |
| 2019-12-31 | GBX71.17 Million ≈ $8.66K |
GBX5.10 Million ≈ $620.52 |
0.072x | -44.98% |
| 2018-12-31 | GBX63.90 Million ≈ $7.78K |
GBX8.32 Million ≈ $1.01K |
0.130x | -12.96% |
| 2017-12-31 | GBX60.50 Million ≈ $7.36K |
GBX9.05 Million ≈ $1.10K |
0.150x | +2.02% |
| 2016-12-31 | GBX60.97 Million ≈ $7.42K |
GBX8.94 Million ≈ $1.09K |
0.147x | +260.04% |
| 2015-12-31 | GBX46.75 Million ≈ $5.69K |
GBX-4.29 Million ≈ $-521.36 |
-0.092x | -68.80% |
| 2014-12-31 | GBX87.38 Million ≈ $10.63K |
GBX-4.74 Million ≈ $-577.21 |
-0.054x | -210.70% |
| 2013-12-31 | GBX40.92 Million ≈ $4.98K |
GBX2.01 Million ≈ $244.19 |
0.049x | +20.93% |
| 2012-12-31 | GBX39.43 Million ≈ $4.80K |
GBX1.60 Million ≈ $194.55 |
0.041x | +288.32% |
| 2011-12-31 | GBX37.43 Million ≈ $4.55K |
GBX-806.00K ≈ $-98.07 |
-0.022x | +64.04% |
| 2010-12-31 | GBX23.53 Million ≈ $2.86K |
GBX-1.41 Million ≈ $-171.43 |
-0.060x | +50.22% |
| 2009-12-31 | GBX5.62 Million ≈ $683.79 |
GBX-676.00K ≈ $-82.25 |
-0.120x | +5.74% |
| 2008-12-31 | GBX5.07 Million ≈ $616.87 |
GBX-647.00K ≈ $-78.72 |
-0.128x | -210.05% |
| 2007-12-31 | GBX4.98 Million ≈ $605.44 |
GBX577.00K ≈ $70.20 |
0.116x | +160.35% |
| 2006-12-31 | GBX4.30 Million ≈ $523.06 |
GBX-826.00K ≈ $-100.50 |
-0.192x | -3668.00% |
| 2005-12-31 | GBX3.71 Million ≈ $451.89 |
GBX20.00K ≈ $2.43 |
0.005x | +101.97% |
| 2004-12-31 | GBX3.12 Million ≈ $379.01 |
GBX-852.00K ≈ $-103.66 |
-0.274x | -2390.00% |
| 2003-12-31 | GBX2.46 Million ≈ $299.07 |
GBX-27.00K ≈ $-3.29 |
-0.011x | -498.46% |
| 2002-12-31 | GBX2.90 Million ≈ $353.09 |
GBX8.00K ≈ $0.97 |
0.003x | -99.58% |
| 2001-12-31 | GBX214.00K ≈ $26.04 |
GBX142.00K ≈ $17.28 |
0.664x | -- |
About EKF Diagnostics Holdings Plc
EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more